Pancreatic Cancer Drug
-
{
- All
- News
-
Exclusive: Biggest Pancreatic Cancer Breakthrough In 50 Years, Says Indian Doctor, Co-Author Of Global Clinical Trial
Daraxonrasib belongs to a new class of medicines known as RAS(ON) inhibitors. The drug targets the active form of RAS proteins, which help drive tumour growth and survival.
-
Major Breakthroughs In Pancreatic Cancer Treatment And Weight Loss Medication Benefits Discussed At ASCO Summit
Cancer researchers highlighted several treatment breakthroughs during their annual summit in Chicago that concluded Tuesday, including preliminary but encouraging data on potential...
-
Pancreatic Cancer Breakthrough: New Daily Pill Doubles Survival Time For Advanced Patients
A new once-daily targeted therapy, daraxonrasib, has nearly doubled survival in patients with advanced pancreatic cancer in a landmark Phase 3 trial. Experts are calling it one of the most significant breakthroughs against one of the world's deadliest cancers in decades.
-
Experimental Pill Promises New Hope For Deadly Pancreatic Cancer
The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a target that had eluded treatment for decades.
-
Doctors Tell Soha Ali Khan Price Of Mounjaro After Aishwarya Mohanraj's Video
The cost of weight-loss drugs has reduced, and according to the experts, it will continue to come down
-
Scientists Cure Pancreatic Cancer In Mice Without Major Side Effects
Scientists achieved pancreatic cancer tumour disappearance in mice using a triple combination therapy, paving the way for future clinical trials.
-
New Implantable Device May Help Shrink Pancreatic Tumours
MIT researchers have developed a small, implantable device that delivers chemotherapy drugs directly to pancreatic tumours, and can potentially help shrink the tumours to a size where a surgeon can remove them.
-
Diabetes Drug May Slow Growth Of Pancreatic Cancer: Study
Researchers including those of Indian-origin may have uncovered a novel mechanism behind the ability of the diabetes drug metformin to inhibit the progression of pancreatic cancer.
-
Diabetes Drug Slows Down Growth Of Pancreatic Cancer
Researchers are likely to have uncovered a novel mechanism behind the ability of the common diabetes drug - metformin -- to inhibit the progression of pancreatic cancer.
-
Anti-Cancer Drug Made More Effective To Reduce Side Effects
Researchers have found a way to make an existing drug used to treat breast, lung and pancreatic cancers effective in small dosage, thereby reducing its usage and associated side effects in course of the treatment.
-
Existing Drugs Could Treat Gastric Cancer
Certain drugs currently used to treat breast, ovarian and pancreatic cancers, could also be used to treat some gastric cancers, researchers have found.
-
Drug Combo Could Combat Pancreatic Cancer
Pairing an experimental drug with an existing one could provide a more effective way to treat a form of pancreatic cancer than a single drug, new research has found.
-
Exclusive: Biggest Pancreatic Cancer Breakthrough In 50 Years, Says Indian Doctor, Co-Author Of Global Clinical Trial
Daraxonrasib belongs to a new class of medicines known as RAS(ON) inhibitors. The drug targets the active form of RAS proteins, which help drive tumour growth and survival.
-
Major Breakthroughs In Pancreatic Cancer Treatment And Weight Loss Medication Benefits Discussed At ASCO Summit
Cancer researchers highlighted several treatment breakthroughs during their annual summit in Chicago that concluded Tuesday, including preliminary but encouraging data on potential...
-
Pancreatic Cancer Breakthrough: New Daily Pill Doubles Survival Time For Advanced Patients
A new once-daily targeted therapy, daraxonrasib, has nearly doubled survival in patients with advanced pancreatic cancer in a landmark Phase 3 trial. Experts are calling it one of the most significant breakthroughs against one of the world's deadliest cancers in decades.
-
Experimental Pill Promises New Hope For Deadly Pancreatic Cancer
The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a target that had eluded treatment for decades.
-
Doctors Tell Soha Ali Khan Price Of Mounjaro After Aishwarya Mohanraj's Video
The cost of weight-loss drugs has reduced, and according to the experts, it will continue to come down
-
Scientists Cure Pancreatic Cancer In Mice Without Major Side Effects
Scientists achieved pancreatic cancer tumour disappearance in mice using a triple combination therapy, paving the way for future clinical trials.
-
New Implantable Device May Help Shrink Pancreatic Tumours
MIT researchers have developed a small, implantable device that delivers chemotherapy drugs directly to pancreatic tumours, and can potentially help shrink the tumours to a size where a surgeon can remove them.
-
Diabetes Drug May Slow Growth Of Pancreatic Cancer: Study
Researchers including those of Indian-origin may have uncovered a novel mechanism behind the ability of the diabetes drug metformin to inhibit the progression of pancreatic cancer.
-
Diabetes Drug Slows Down Growth Of Pancreatic Cancer
Researchers are likely to have uncovered a novel mechanism behind the ability of the common diabetes drug - metformin -- to inhibit the progression of pancreatic cancer.
-
Anti-Cancer Drug Made More Effective To Reduce Side Effects
Researchers have found a way to make an existing drug used to treat breast, lung and pancreatic cancers effective in small dosage, thereby reducing its usage and associated side effects in course of the treatment.
-
Existing Drugs Could Treat Gastric Cancer
Certain drugs currently used to treat breast, ovarian and pancreatic cancers, could also be used to treat some gastric cancers, researchers have found.
-
Drug Combo Could Combat Pancreatic Cancer
Pairing an experimental drug with an existing one could provide a more effective way to treat a form of pancreatic cancer than a single drug, new research has found.
